The C/EBP␤ (CCAAT/enhancer-binding protein ␤) is a transcription factor that belongs to basic region-leucine zipper class DNA-binding proteins. There is a significant body of evidence that suggests that this protein plays a central role in adipocytic and eosinophilic differentiation. However, there is no information available regarding the role of this transcription factor in the development of mammalian neuronal tissues. In this study, we have examined the effect of C/EBP␤ overexpression on the differentiation and survival of mouse Neuro2A cells. We found that C/EBP␤ induces neuronal differentiation and that this process is inhibited by transfection with the C/EBP homologous protein 10 (CHOP), strongly suggesting that the extension of neurites is indeed due to the C/EBP␤ transcriptional activity. As it has been suggested in adipocyte differentiation, here we show that C/EBP␤ induces the expression of the endogenous C/EBP␣ gene and that this protein by itself is also able to induce a differentiated phenotype in Neuro2A cells. Neuronal differentiation induced by C/EBP␤ requires activation of the phosphatidylinositol 3-kinase signaling pathway, whereas inhibition of the mitogen-activated protein kinase signaling does not have any effect. In addition, we show that C/EBP␤ is expressed in the brain of neonatal rats, suggesting that this protein could play an important role in neuronal maturation. Finally, cell death was also induced by C/EBP␤ through activation of the p53 protein and the cdk inhibitor p21.
Neuritogenesis is a central event in brain development, and its regulation during neuronal differentiation is complex and likely to involve multiple signaling systems and the regulation of a wide set of genes. Research over the past few years has given us a glimpse of the molecules involved in dendritic morphogenesis. Proper dendrite development relies on extracellular signals and the signal transduction that lies downstream of them (1) . This signal transduction includes local regulation of dendritic structures via the cytoskeleton and regulation mediated through changes in the transcription of target genes. Therefore, the identification of molecules involved in dendritic morphogenesis is an essential step toward understanding how dendrites develop. Due to the complexity of the developing nervous system, many studies, including the one described here, have used in vitro model systems to gain a better understanding of the mechanisms that regulate neuritogenesis (2) (3) (4) (5) . These in vitro systems have also been widely used to study neuronal programmed cell death and the characterization of the genes implicated in its regulation. The present study investigates the role of the CCAAT/enhancer-binding protein ␤ (C/EBP␤) 1 gene on neurite outgrowth and apoptosis of Neuro2A (N2A) cells. The C/EBP family of transcription factors is composed of at least five distinct members (C/EBP␣, C/EBP␤, C/EBP␦, C/EBP⑀, and C/EBP␥) (6) . These proteins are known to be involved in the regulation of cell growth and differentiation of several cell types. Common structural features of these proteins are highly conserved DNA binding and leucine zipper dimerization domains at the carboxyl terminus and divergent amino termini containing regulatory and transactivation domains (7, 8) . Initially, C/EBP␤ has been linked to hepatocyte-specific gene regulation because it shows high expression in liver cells (9) and binds to regulatory elements in the promoter of liver-specific genes (10) . In addition, it has been suggested that C/EBP␤ contributes to regulate the acute phase response of the liver (11) . Lately, it has become clear that C/EBP␤ also plays a role in other tissues. Results derived from experiments in cell culture and with knockout mice have demonstrated that this protein is critical for lymphocyte (12, 13) and adipocyte differentiation (14, 15) . The role of different C/EBP proteins during adipocyte differentiation is thought to follow a sequential model during which C/EBP␦ and C/EBP␤ expression precede expression of C/EBP␣ and correlates with induction of differentiative events (15) . In fact, expression of C/EBP␣ is primarily restricted to highly differentiated cells such as hepatocytes, adipocytes, and type II cells of the lung (16) . This sequential expression of C/EBP isoforms, together with the fact the C/EBP␣ promoter contains a C/EBP response element, has led to the idea that C/EBP␤ can activate the expression of the C/EBP␣ promoter during differentiation processes such as adipose conversion.
The activity of the transcription factor C/EBP␤ can be controlled by phosphorylation. Previous studies have shown that extracellular stimuli can alter the phosphorylation of several sites in C/EBP␤ and can modify their effects on promoter activity. Increased transcriptional activities through phosphorylation of distinct sites in rat, chicken, or human C/EBP␤ are regulated by many different stimuli of cell proliferation and differentiation, such as phorbol esters/protein kinase C-␣, v-erbB, and ras (17, 18) , suggesting a link among these posttranslational modifications, transcriptional activation, and cell function. It has also been reported that phosphorylation of the C/EBP␤ protein after insulin stimulation reduces transactivation by interfering with DNA binding or by disrupting interactions with p300/CBP proteins (19) . Regarding a possible role of C/EBP␤ in the brain, it has been shown that C/EBP␤ mRNA is widely expressed in the adult mouse brain (20) . Expression of this protein has also been reported in the PC12 cell line, which undergoes differentiation to neuron-like cells in response to nerve growth factor (20) . In these cells, nerve growth factor receptor signaling stimulates activity of C/EBP␤. However, the function of C/EBP␤ within the mammalian nervous system is unknown. In the invertebrate Aplysia, it has been shown that the transcription factor Aplysia CCAAT enhancer-binding protein (ApC/EBP) plays an essential role in the consolidation of stable long term synaptic plasticity (21) . More recent studies in mammals have suggested an implication of C/EBP␤ and C/EBP␦ in long term synaptic plasticity and memory consolidation in rat hippocampus (22) . Here we show that stabletransfected N2A cells overexpressing the C/EBP␤ protein present a differentiated phenotype and extend very long neurites even when growing in the presence of serum. This induction of differentiation is accompanied by an increase in the expression of genes associated with the differentiated state and requires activation of phosphatidylinositol 3-kinase (PI3K). The neurite outgrowth activity was specific to C/EBP␤ transactivation capacity because CHOP (C/EBP homologous protein 10), a dominant negative of this protein, inhibited this outgrowth. In addition, C/EBP␤ promotes N2A apoptosis, which is dependent on p53. Finally, we also found that the C/EBP␤ protein is broadly distributed in the brain of neonatal rats during a period of intense neuronal maturation. Together, these results suggest that the C/EBP␤ protein may play an important role in neuronal maturation and cell death during mammalian brain development.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection-Mouse N2A cells were grown in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum (Invitrogen) and 2 mM glutamine at 37°C. For the selection of stably transfected cells, 0.5 ϫ 10 6 cells were seeded into a 6-cm diameter tissue culture plate and incubated overnight. The following day, the medium was aspirated, and the cells were washed twice with TD buffer (20 mM Tris-HCl, pH 7.4, 1 mM Na 2 HPO 4 , 140 mM NaCl, 5 mM KCl) and transfected with 2 g of pMSV-C/EBP␤ (kindly provided by Dr. McKnight, University of Texas, Dallas, TX) by the calcium phosphate precipitation technique as described previously (23) . Twelve h after transfection, the medium was replaced with regular growth medium, and the cells were incubated for 24 h, after which they were subcultured at 1:10 dilution with the addition of geneticin (1 mg/ml). The growth medium was renewed every 3 days, and fresh geneticin was added. Cultures were expanded and then screened for C/EBP␤ expression. For transient transfection experiments (C/EBP␣ promoter, pG13-luc, and MG15-luc), semiconfluent cells were transfected by the calcium phosphate precipitation technique in 24-well plates. After 8 h of exposure to the Ca 2ϩ /DNA mixture, cells were washed with TD buffer, incubated for another 24 h in regular medium, and harvested for determination of luciferase activity as described previously (24) . Each transient transfection experiment was repeated at least three times in duplicate. For the experiment shown in Fig. 3B , the p4 pool was cotransfected with a CHOP expression vector together with a GFP (green fluorescent protein) construct (CLONTECH, Palo Alto, CA) at a ratio of 5:1 by the calcium phosphate method. Twenty-four h after transfection, cell morphology was examined with a Zeiss Axiovert microscope. For transient transfection experiments with the constitutively active p110 subunit (K227E) of PI3K, N2A and p4 were transfected using Transfast (Promega, Madison, WI), following the manufacturer's instructions to achieve a high efficiency of transfection (Ͼ80%).
For overexpression of C/EBP␣ protein, full-length C/EBP␣ was cloned into the pLXSN retroviral vector (CLONTECH). BOSC23 packaging cells were grown in 60-mm dishes and transfected by the calcium phosphate method. Recombinant retroviral particles were collected from the supernatant 2 days later and used to infect N2A and p4 cells. Two days later, cell morphology was examined with a Zeiss Axiovert microscope.
The rat C/EBP␣ promoter construct pC/EBP⌬380 has been described previously (24) . pG13 and MG15 reporter plasmids were provided by B. Vogelstein (The Johns Hopkins Oncology Center, Baltimore, MD) (25) , and CHOP, C/EBP␣, and K227E p110 expression constructs were provided by N. Holbrook (National Institutes of Health, Baltimore, MD), Dr. McKnight, and J. Downward (Imperial Cancer Research Fund, London, UK), respectively (14, 26, 27) . For morphological analysis, cells were seeded at a density of 20,000/cm 2 and grown for 24 h in complete medium, and then some of the plates were placed in serum-free medium and observed 6 h after serum withdrawal. Some cultures were treated with LY294002 (Calbiochem, Nottingham, UK), a reversible inhibitor of PI3K used at 10 M, or PD98059 (Calbiochem), an inhibitor of MEK1 and MEK2 used at 80 M.
Antibodies-The DF77 polyclonal antibody specific for the C/EBP␤ was obtained by injecting rabbits with a peptide corresponding to the amino-terminal portion of this protein (nucleotides 108 -419) fused to the glutathione S-transferase protein. The specificity of the antibody was confirmed by incubating the antibody with immunizing peptide (1 M) for 4 h at 4°C before Western blotting and also by comparing the signal obtained with this antibody with an anti-C/EBP␤ commercially available antibody and an anti-C/EBP␤ kindly provided by Dr. McKnight. Monoclonal anti-MAP2 and anti-NeuN antibodies were from PharMingen (San Diego, CA) and Chemicon (Temecula, CA), respectively. The polyclonal anti-C/EBP␣, commercial anti-C/EBP␤, anti-p21, and monoclonal anti-p53 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA).
Immunoblotting-N2A cells were washed twice with TD followed by centrifugation at 200 ϫ g for 5 min. The cell pellet was resuspended in 500 l of extraction buffer (phosphate-buffered saline containing 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, and protease inhibitors). Cells were disrupted by repeated aspiration through a 21-gauge needle, incubated on ice for 30 min, and spun at 12,000 ϫ g for 20 min. Supernatants were removed and stored at Ϫ70°C until analysis by gel electrophoresis. Brain protein extracts were obtained as described previously (28) . Twenty g of protein extracts were loaded onto each lane of a 10% SDS-polyacrylamide gel, separated, and then blotted to nitrocellulose membranes at 90 mA overnight in transfer buffer (25 mM Tris, pH 8.3, 190 mM glycine, 20% methanol, 0.5% SDS). Protein loading and transference were checked by Red Ponceau staining of the membranes. For immunoblotting, membranes were blocked with 5% non-fat milk in TBST buffer (20 mM Tris-HCl, pH 7.6, 130 mM NaCl, 0.1% Tween 20) for 1 h at room temperature, incubated with the corresponding primary antibody in TBST buffer with 5% non-fat milk for 2 h, and after several washes, subsequently incubated with a horseradish peroxidase-coupled secondary antibody (1:5000) in the same buffer. After washing, immunoreactive bands were visualized using the ECL detection kit (Amersham Biosciences, Inc.) according to the manufacturer's instructions.
Immunofluorescence Studies-Cells were grown on glass coverslips for 24 h, fixed for 10 min with methanol at Ϫ20°C, and permeabilized with 0.1% Triton X-100 for 30 min at 37°C. After a 1-h incubation with the primary antibody, cells were washed with phosphate-buffered saline and incubated with the corresponding fluorescein-labeled second antibody for 45 min at 37°C. The cells were then examined with a Zeiss Axiophot microscope.
Apoptosis Assay-To calculate the percentage of cell death, 0.5 ϫ 10 6 cells were seeded in 6-cm diameter tissue culture plates and grown in Dulbecco's modified Eagle's medium for 24 h before switching to Dulbecco's modified Eagle's medium without fetal bovine serum for a further 24 h. For analysis, both the floating cells in the supernatant and the phosphate-buffered saline wash containing the cells were collected from each plate. Apoptosis was assayed using PI staining and fluorescence-activated cell sorter analysis. Cells were analyzed in a FACSscan flow cytometer (Becton Dickinson and Co., Bedford, MA), and the for-ward scatter was plotted against the propidium iodide fluorescence. The data were analyzed using the Cell Quest software package (Becton, Dickinson and Co.).
Statistical Analysis-The data were analyzed using the Excell software package. Significant effects were determined using Student's t test. A statistically significant difference was considered to be present at p Ͻ 0.05.
RESULTS

Expression of the C/EBP␤ Protein in Different Brain
Regions-The results of in situ hybridization showing a high level of expression of the C/EBP␤ mRNA in neural tissue (20) prompted us to investigate the presence of the C/EBP␤ protein in different brain regions. For this purpose, we raised a polyclonal antibody against a peptide corresponding to the aminoterminal portion of the C/EBP␤ protein, which corresponds to the most divergent peptide sequence from the other homologous members of the C/EBP family of transcription factors. Western blot analysis of total protein extracts prepared from different brain regions isolated from 15-day-old rats showed a prominent expression of the C/EBP␤ protein in all the regions studied. However, this expression was slightly higher in the cerebellum (Fig. 1) . C/EBP␤ protein was also present in the brain of 5-day-old neonates (data not shown). The same pattern of expression was obtained with a commercial anti-C/EBP␤ antibody (Santa Cruz Biotechnology) and with the c76 polyclonal anti-C/EBP␤ antibody provided by Dr. McKnight (data not shown). These data, together with the results presented in Fig. 2A showing a high level of expression of the C/EBP␤ protein in the stable transfected N2A cells, demonstrate the specificity of the DF77 antibody.
Forced Expression of C/EBP␤ Leads to Premature Neuronal Differentiation-To directly assess the participation of the C/EBP␤ protein in neuronal function, we generated stably transfected N2A cell lines. The complete C/EBP␤ cDNA, cloned into an murine sarcoma virus (MSV)-driven expression vector, was transfected into N2A cells, and different pools of G418-resistant clones were tested for C/EBP␤ expression using the DF77 polyclonal antibody. For the rest of the experiments, we chose to use pool p4, which showed very high levels of C/EBP␤ protein ( Fig. 2A) as compared with parental N2A cells. The differences in the amount of C/EBP␤ protein between parental N2A and p4 cells can also be observed by immunofluorescence analysis (Fig. 2B) . In parental N2A cells, a weak and diffuse signal can be observed in contrast with a much stronger signal detected in pool p4, which is clearly localized in the nucleus. Because the C/EBP␤ protein is a member of a diverse group of transcription factors, its nuclear localization is obviously essential for its subsequent transactivation of target genes. The morphologies of N2A wild type and p4 cells were observed 24 h after they were plated in the presence of 10% fetal bovine serum. As is apparent from the micrographs in Fig. 3A , overexpression of C/EBP␤ induced a dramatic morphological change. We observed a pronounced difference in the phenotype of the parental N2A cells and pool p4 overexpressing the C/EBP␤ protein. More than 90% of the control cells showed a round morphology, typical of an undifferentiated state, whereas around 75% of neuroblastoma cells expressing the C/EBP␤ protein displayed a more differentiated phenotype. Moreover, when the cells were grown for a further 6 h in serum-free medium (serum starvation induces spontaneous process outgrowth in these cells), almost 100% of p4 cells expressing C/EBP␤ had very long and branched neurites, at least two cell bodies in diameter, whereas parental N2A cells only started to extend short projections. The transcription factor CHOP (C/EBP homologous protein 10, also known as GADD153) acts as a dominant negative regulator of C/EBPs by forming stable heterodimers with these proteins and preventing them from binding to DNA (29, 30) . Therefore, to ensure that the neurite outgrowth activity in the p4 pool was in fact mediated by the expression of the C/EBP␤ protein, pool p4 was transiently cotransfected with a plasmid expression vector for CHOP and GFP. After transfection, cells were maintained in culture under growth conditions for 24 h. Transfected cells could be identified by GFP fluorescence. Twenty four h after transfection, most GFP-expressing cells (80%) adopted a round morphology. In contrast, we rarely found GFP-expressing cells with a differentiated phenotype, suggesting that the phenotype observed was indeed due to C/EBP␤ overexpression (Fig. 3B) . To examine whether phosphorylation of C/EBP␤ is required for the morphological changes observed in p4, we used inhibitors of MAPK (Erks) and PI3K signaling pathways. As shown in Fig.  4 , the change in cell morphology induced by C/EBP␤ in the p4 cells was completely blocked by pretreatment of cells with the PI3K inhibitor LY294002 but not with the MEK inhibitor PD98059, suggesting that the PI3K pathway, but not the MAP kinase pathway, is required for C/EBP␤-induced neurite outgrowth. These results were further confirmed by transient transfection of p4 cells with a constitutively active p110 subunit (K227E) of PI3K. As shown in Fig. 4 , transfection with the Myctagged K227E p100 plasmid significantly increased the number of cells with a differentiated phenotype, as well as the number of neurites/cell and the length of these prolongations. In contrast, parental N2A cells transfected with the same construct did not show any significant change in cell morphology, suggesting that in fact, C/EBP␤ is required for the effects triggered by PI3K activation. We next examined the levels of two neuronal-specific markers: microtubule-associated protein 2 (MAP2) and NeuN in parental N2A and p4 cells. A striking difference was observed between parental N2A cells and p4. Under basal conditions (cells growing in the presence of fetal bovine serum for 24 h), only a low amount of MAP2 protein could be found in N2A non-transfected cells, and very few immunoreactive MAP2-expressing cells were observed (Fig. 5, A and B) , which is in agreement with the undifferentiated phenotype presented by these cells. On the contrary, Western blot analysis showed a significant increase in the amount of MAP2 protein in cells overexpressing C/EBP␤. Increased expression of MAP2 protein was also confirmed by immunofluorescence wherein pool p4 showed a very strong signal, in contrast to the very weak signal observed in N2A progenitor cells. Similar results were observed with NeuN, a neuronal cell type-specific nuclear protein expressed in postmitotic neurons (31) .
As can be shown in Fig. 5A , basal levels of NeuN immunoreactivity can be found in parental N2A cells, and these levels are significantly enhanced in p4 cells. Immunofluorescence studies revealed that this protein is localized in the nucleus, as expected (Fig. 5C ). We next determined whether, as happens during adipocyte differentiation, the expression of C/EBP␣ could be increased in N2A cells overexpressing C/EBP␤ protein and therefore whether C/EBP␣ could play a role in maintaining the neuronal differentiated phenotype. Our results show a striking increase in the amount of endogenous C/EBP␣ protein in p4 cells, as determined by immunofluorescence (Fig. 6A ) and Western blot (Fig. 6B ) analysis. We also tested whether the increase in the levels of C/EBP␣ protein could be due to a direct effect of C/EBP␤ on C/EBP␣ promoter activity. To this end, we performed transient transfections in parental N2A and in p4 cells with a reporter construct containing 380 bp of the promoter region of the C/EBP␣ linked to a luciferase reporter gene. As shown in Fig. 6C , transactivation of the reporter construct was significantly increased (5.5-fold) in cells stably expressing the C/EBP␤ protein, suggesting that the observed increase in the amount of C/EBP␣ protein is due, at least in part, to an induction in the transcription of this gene by C/EBP␤. Finally, we tested whether C/EBP␣ itself could induce parental N2A differentiation and also produce a more differentiated phenotype in cells overexpressing C/EBP␤. Consequently, we infected parental N2A and p4 cells with a retroviral expression vector for C/EBP␣. As shown in Fig. 7, 2 days after viral infection, more than 60% of parental N2A cells had a differentiated phenotype, as compared with 15% in N2A cells transfected with the empty vector. P4 cells overexpressing C/EBP␣ presented very long neurites, a feature of mature neurons. Altogether, these results suggest a potential role of the C/EBP␣ gene in the induction and maintenance of the neuronal-differentiated state.
Effect of C/EBP␤ Overexpression on Cell Death-Apoptotic cell death of differentiating cells is found widely in the developing brain. In vitro, apoptosis is also observed during the course of neuronal differentiation of N2A cells. We have therefore analyzed whether C/EBP␤ could induce this process in N2A cells. To test this premise, we examined apoptotic cell death with PI staining and fluorescence-activated cell sorter analysis to score the number of apoptotic cells in N2A progenitor cells and p4 cells 24 h after serum withdrawal. In cultures growing in regular medium, fewer than 8% of the N2A cells manifested apoptotic features (data not shown). After 24 h of serum withdrawal, up to 11.8% of the parental N2A cells were PI ϩ , and a significant enhancement of the apoptotic population can be observed in p4 cells (19.6%) (Fig. 8) . These data indicate that, in addition to inducing neuronal differentiation, C/EBP␤ is a potent inducer of programmed cell death in N2A cells.
Tumor suppressor p53 plays a key role in the control of apoptosis, and its inactivation is a common event in human tumors (32) . Expression of p53 protein results in apoptosis in numerous cell lines. To investigate whether the enhanced apoptosis observed in p4 cells could be mediated by the p53 protein, we first performed Western blot analysis with a specific anti-p53 antibody. As shown in Fig. 9A , although the level of p53 protein is not altered in p4 cells as compared with parental N2A cells, we could observe a shift in the mobility of the protein in the cells overexpressing C/EBP␤, suggesting a possible phosphorylation/activation of this factor. To test this hypothesis, we next performed transient transfection experiments using the reporter construct pG13-luc, which contains multiple p53 binding sites linked to a basal promoter (25) . As can be seen in Fig.  9B , when the p53 reporter construct pG13-luc was transfected into N2A cells and the p4 pool, a clear induction of luciferase activity was observed in p4 cells, suggesting that, although we did not observe any increase in the amount of p53, there is an activation of this protein in the stably transfected cells. As a control, when these cells were transfected with the reporter construct MG15-luc (containing mutations in the p53 binding sites), no significant increase in luciferase activity was observed in the N2A overexpressing the C/EBP␤ protein. To confirm the activation of p53 in p4, we analyzed the levels of p21, a well known downstream gene of p53. Using the same protein extracts, we could observe a significant increase in the levels of p21 in p4 cells as compared with parental N2A cells (Fig. 9A) . These experiments clearly demonstrate the ability of C/EBP␤ to induce the activity and/or expression of two cell cycle-related proteins shown to play a role in the apoptotic pathway.
DISCUSSION
The molecular mechanisms regulating the differentiation and death of neuronal cells during the development of the nervous system are very complex, and their regulation implicates the action of numerous genes (1) . In this study, we have used Neuro2A cells, a well studied model of differentiation and cell death (3) , to show that overexpression of the transcription factor C/EBP␤ clearly promotes neuronal differentiation. This promotion of neurite outgrowth is accompanied by an increase in the expression of neuronal differentiation markers such as MAP2 and NeuN. We also show that the C/EBP␤ protein is widely distributed in the brain of postnatal rats, a period of time during which the dendritic arbor of neurons develops (33) . In addition, C/EBP␤ overexpression significantly increases programmed cell death, probably through a mechanism involving the cell cycle-dependent proteins p53 and p21. These results suggest that C/EBP␤ may play an important role in the regulation of neuronal differentiation and cell death.
In the brain, recent in situ hybridization studies have shown that C/EBP␤ mRNA is widely expressed in the adult mice and is mainly located in neurons (20) . In agreement with these results, we show here that the C/EBP␤ protein is also widely expressed in the neonatal rat brain (Fig. 1) , a period of intense neuronal maturation. Regarding a possible role of C/EBP␤ in the brain, studies of long term facilitation using cultured neurons of the marine mollusk Aplysia have provided evidence for a role of an Aplysia C/EBP homologue (ApC/EBP) in synaptic plasticity. Stimulation of cyclic AMP signaling pathways induced the expression of this protein, and injection of antiserum against ApC/EBP demonstrated its critical role in the establishment of long term facilitation (21) . In mammals, it has been shown that the expression and DNA binding activities of C/EBP␤ and C/EBP␦ are enhanced by the stimulation of cAMP or Ca 2ϩ signals in cultured hippocampal neurons (22), suggesting a possible involvement of these genes in long term plasticity in mammalian brain. It has been also shown that rat C/EBP␤ and C/EBP␦ proteins are induced after inhibitory avoidance learning and that they colocalize with phosphorylated cAMPresponse element-binding protein in the hippocampus (34) . This induction is blocked by fornix lesions, a manipulation that is known to impair memory consolidation. Very recently, Taubenfeld et al. (35) have directly demonstrated that in mammals, the consolidation of new but not reactivated memory requires C/EBP␤.
Here we show that overexpression of C/EBP␤ in N2A cells promotes neuronal differentiation, as measured by neurite outgrowth and expression of the neuronal markers MAP2 and NeuN. These observations, along with the presence of C/EBP protein in the brain of developing rats and its neuronal localization (according to the in situ studies (20) ) suggest that this protein could participate in the regulation of growth of neuronal processes in the developing brain. The effect of C/EBP␤ on neurite outgrowth observed here is specific to this protein and mediated by its transactivation capacity because the abrogation of this transactivation potential (by the dominant negative CHOP) completely blocks neurite extension. These results are in line with previous studies showing an implication of the C/EBP␤ protein in the differentiation of non-neuronal tissues (12, 36) .
Neurite outgrowth depends on the increased assembly of microtubules, which constitute the cytoskeletal scaffolding of developing neurites (2, 37, 38) . During this event, both an increase in the expression of microtubule proteins and posttranscriptional modifications take place (2, 39, 40) . The microtubule-associated protein MAP2 plays an important role in tubuline polymerization and is necessary for the initial formation of neurites (39, 41) . Expression of MAP2 antisense transcripts in P19 embryonic carcinoma cells undergoing retinoic acid-induced neuronal differentiation results in a significant reduction in the number of neurites observed (42) . Also, it has been reported that blocking the expression of MAP2 with antisense oligonucleotides results in a suppression of the outgrowth of neurites in cultured cerebellar macroneurons (43) . The results presented here show that C/EBP␤ regulates the expression of MAP2 because a robust increase in the levels of MAP2 protein is observed in cells overexpressing C/EBP␤, suggesting that MAP2 is involved in C/EBP␤ action on neurite extension.
In non-neuronal cells, such as 3T3-L1, it has been shown that C/EBP␤ is expressed early in the differentiation program (36) , and this induction is thought to be responsible for the later transcriptional activation of C/EBP␣, another member of this family. Among other effects, it has been described that the expression of C/EBP␣ is necessary for the maintenance of the differentiated state of adipose and hepatic tissues (44) , and ectopic expression of this protein in several fibroblastic cell lines is sufficient to induce adipocyte differentiation (45) . Here we show that C/EBP␤ induces the expression of the endogenous C/EBP␣ gene in N2A cells because a significant increase in the endogenous levels of this protein is observed in the C/EBP␤-overexpressing cells. This is associated with an enhancement of the promoter activity of the C/EBP␣ gene, which contains a C/EBP␤ consensus binding site. In addition, when p4 cells are infected with a retroviral expression vector for C/EBP␣, a more differentiated phenotype can be observed. Interestingly, overexpression of C/EBP␣ in parental N2A also results in an induction of differentiation, suggesting that this protein by itself is able to trigger neuronal differentiation. Altogether, these results suggest that, similarly to the proposed model for adipocyte differentiation, C/EBP␤ seems to regulate C/EBP␣ gene expression in neuroblastoma cells, and this in turn would also play an important role in the neuronal differentiation of these cells.
Transcription factor phosphorylation is a common way of control of transcriptional activity (46, 47) . It is well established that C/EBP␤ is a nuclear end point for several protein kinasemediated pathways (19, 47, 48) . Activation of cAMP-dependent protein kinase in rat pheochromocytoma PC12 cells increases phosphorylation and nuclear translocation of C/EBP␤ and a concomitant induction of c-fos transcription (48) . Site-selective phosphorylation of C/EBP␤ at Ser 105 by protein kinase C enhances C/EBP␤ transactivation activity in HepG2 cells (49) . More recently, Piwien-Pilipuk et al. (50) have also shown that growth hormone regulates the phosphorylation and function of C/EBP␤ by modulating the PI3K pathway. The results presented here clearly show that activation of the PI3K signaling pathway by expression of the constitutively activated K227E mutant increased neuronal differentiation in cells overexpressing C/EBP␤, whereas activation of this pathway had no effect on parental N2A cells. Consistently, a PI3K inhibitor, LY294002, inhibited neurite outgrowth. This process was unaffected by the MEK inhibitor PD98059. Taken together, these data suggest that C/EBP␤-mediated neuronal differentiation requires activation of the PI3K pathway.
At a certain stage during the development and differentiation of the vertebrate nervous system, the massive scale death of neurons and oligodendrocytes occurs as part of the normal physiological process (51, 52) . This neuronal cell death has been shown to occur via apoptosis (53) . The results presented here demonstrate that overexpression of C/EBP␤ causes a significant increase in the apoptotic population of N2A cells, which is in agreement with previous reports showing a role of the C/EBP␤ protein in the induction of apoptosis in hematopoietic and myeloma cells (12, 54) . This apoptotic process appears to implicate at least two cell cycle-dependent proteins in the mediation of this effect, p53 and p21. C/EBP␤ does not enhance the levels of p53 protein, but it is able to trigger its activation, as shown by the observed increase in the transactivation of a p53-responsive promoter in C/EBP␤-overexpressing cells (Fig.  9) . It has been shown that the DNA binding and transcriptional activity of p53 can be modulated by phosphorylation (55) (56) (57) and that this phosphorylation can induce a shift in the migration of this protein in an SDS gel (58) , similar to the one described here. These data suggest that the apoptosis induced by C/EBP␤ in N2A cells could be mediated by an increase in p53 phosphorylation and the subsequent enhancement in its transactivation activity. The increase in p21 protein levels detected in C/EBP␤ overexpressing cells could be due to an increase in p53 activity or to a direct regulation of p21 gene expression by the C/EBP␤ itself because, although it is well established that p53 regulates the expression of the p21 gene (59, 60) , it has also been shown that p21 can be directly regulated by members of the C/EBP family in other cell systems (61, 62) .
In summary, our results identify C/EBP␤ as a potent inducer of neurite outgrowth and apoptosis of neuroblastoma cells and suggest a potential role of this transcription factor in the developing brain because the C/EBP␤ protein is present in this organ during the developmental period.
